In Silico Modelling: The Future of Drug Development
The ERAMET project is transforming the development and approval of way drugs for rare and paediatric diseases. are developed and approved. With 30 million people affected by rare conditions across…
The draft ICH General Principles for MIDD guideline is now available!
ERAMET Contributed to Draft ICH General Principles for MIDD GuidelineThe coordinators of the ERAMET project have actively participated in the development of the Draft ICH General Principles for Model-Informed Drug…
ERAMET Presentation at PKUK 2024 in Bracknell, England
Last November, the ERAMET project was presented at this year’s Pharmacokinetics UK (PKUK) meeting, an important event where experts in drug research gather to share ideas and advancements. This two-day…